Assessment of blood loss and ways of its compensation in patients undergoing orthopedic oncologic surgery (analysis of 7 years’ experience)
Abstract
Background. The goal of study is to estimate blood loss, allogeneic red blood cells, fresh frozen plasma requirement during and after different types of orthopedic oncologic surgery. Methods. From 2006 to 2012, 546 patients undergoing proximal femur, distal femur, total femur, proximal tibia, proximal humeral resections with endoprosthetic reconstruction were enrolled in the retrospective study. Operative blood loss, transfused allogeneic red blood cells, allogeneic fresh frozen plasma was calculated. Results. Median intra / post-operative blood loss by total hip replacement was 800/475, total knee - 600/840, total femur - 1600/1010, hemischoulder arthroplasty - 600/390 ml. Percent of patients received allogeneic red blood cell / fresh frozen plasma was 47/38%, 34/26%, 93/86% and 22/12% accordingly. Massive blood loss during total hip replacement was in 10%, total knee - 2%, total femur - 35%, hemischoulder arthroplasty - 5% of all cases. Conclusions. It was required to treat blood loss per one operated patient (allogeneic red blood cells / fresh frozen plasma) during total hip replacement - 308/312, total knee - 197/151, total femur - 773/700, hemischoulder arthroplasty - 136/92 ml.
References
1. Sarteschi L.M., Pietrabissa A., Boggi U. et al. Minimal blood utilization in surgery. Internal Medicine. 2001, No. 9, p. 19-29.
2. Drueke T. Hyporesponsiveness to recombinant human erythropoietin. Nephrol. Dial. Transplant. 2001, v. 16, Suppl. 7, p. 25-28.
3. Горобец Е.С., Костяк О.С., Буйденок Ю.В. и соавт. Различные аспекты интраоперационной аппаратной Cell-Saver реинфузии аутоэритроцитов в онкологической хирургии. Анестезиология и реаниматология. 2004, № 2, с. 40-43.
4. Karczewski D.M., Lema M.J., Glaves D. The efficiency of an autotransfusion system for tumor cell removal from blood salvaged during cancer surgery. Anesth. Analg. 1994, v. 78, No. 6, p. 1131-1135.
5. Hansen E., Knuechel R., Altmeppen J., Taeger K. Blood irradiation for intraoperative autotransfusion in cancer surgery: demonstration of efficient elimination of contaminating tumor. Transfusion. 1999, v. 39, No. 6, p. 608-615.
6. Anderson M.R., Jeng C.L., Wittig J.C., Rosenblatt M.A. Anesthesia for patients undergoing orthopedic oncologic surgeries. J. of Clin. Anest. 2010, No. 22, p. 565-572.
7. Hansen E., Bechmann V., Altmeppen J. Intraoperative blood salvage in cancer surgery: safe and effective? Transfus. Apher. Sci. 2002, v. 27, No. 2, p. 153-157.
8. Miller G.V., Ramsden C.W., Primrose J.N. Autologous transfusion: an alternative to transfusion with banked blood during surgery for cancer. Br. J. Surg. 1991, v. 78, No. 6, p. 713-715.
9. Torre G.C., Ferrari M., Favre A. et al. A new technique for intraoperative blood recovery in the cancer patient. Eur. J. Sur. Oncol. 1994, v. 20, No. 5, p. 565-570.
10. Perseghin P., Vigano M., Rocco G. et al. Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients. Vox. Sang. 1997, v. 72, No. 4, p. 221-224.
11. Thomas M.J.G. Infected and malignant fields are an absolute contraindication to intraoperative cell salvage: fact or fiction. Transfus. Med. 1999, v. 9, No. 3, p. 269-278.
12. Elias D., Lapierre V., Billard V. Autotransfusion peropératoire par récupération de sang épanché en chirurgie carcinologique. Ann. Fr. d’Anesth. Reanim. 2000, v. 19, No. 10, p. 739-744.
13. Wiesel M., Carl S., Güdemann C. Separation of urological tumor cells by means of a cell saver combined with a membrane filter. A new technique for autotransfusion. J. Urol. (Paris). 1994, v. 100, No. 1, p. 29-32.
14. Hansen E. Failed evidence of tumour cell removal from salvaged blood after leucocyte depletion. Transf. Med. 2006, v. 16, No. 3, p. 213-214.
15. Valbonesi M., Bruni R., Lercari G. Autoapheresis and intraoperative blood salvage in oncologic surgery. Transf. Science. 1999, v. 21, p. 129-139.
16. Joris J. Intra-operative autologous transfusion in cancer patients. Acta Anaesth. Belg. 2004, v. 55, p. 49-51.
17. Poli M., Camargo A., Villa L. et al. Intraoperative autologous blood recovery in prostate cancer surgery: in vivo validation using a tumor marker. Vox. Sanguinis. 2008, v. 95, No. 4, p. 308-312.
18. Мазурок В.А. Особенности раннего послеоперационного периода у онкологических больных с массивной интраоперационной кровопотерей: Диссертация канд. мед. наук. М., 1999.
19. Зуев В.К., Азбаров А.А., Каргин А.Н., Фокин Ю.Н. Аутогемотрансфузия при эндопротезировании коленного и тазобедренного суставов с применением спинально-эпидуральной анестезии. В сб.: Бескровная хирургия - новые направления в хирургии, анестезилогии, трансфузиологии (Под ред. Ю.В. Таричко). М.: МИА, 2003, с. 209-214.
20. Hanlon L., Punzo A., Jones R.A., Speroni K.G. Comparison of cardiopulmonary complication rates in patients undergoing total knee arthroplasty and reinfusion of shed blood. Orthop. Nurs. 2011, v. 30, No. 5, p. 307-311.
21. Горобец E.C., Буйденок Ю.В., Николаева Е.В. Риск переливания крови онкологическим больным. Рос. журн. анестез. и реаниматол. 1999, № 2, с. 55-60.
22. Ness P.M., Walsh P.C., Zahurak M. et al. Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood. Transfusion. 1992, v. 32, p. 31-36.
23. Weber R.S., Jabbour N., Martin R.C. 2nd. Anemia and transfusions in patients undergoing surgery for cancer. Ann. Surg. Oncol. 2008, v. 15, No. 1, p. 34-45.
24. Алиев М.Д., Соколовский В.А., Дзампаев А.З. и соавт. Отдаленные результаты применения мегапротезов в хирургии опухолей костей и суставов. Вестн. Моск. онк. общ. 2011, № 4 (577), с. 2-3.
Review
For citations:
Garyaev R.V. Assessment of blood loss and ways of its compensation in patients undergoing orthopedic oncologic surgery (analysis of 7 years’ experience). Bone and soft tissue sarcomas, tumors of the skin. 2013;(4):10-17. (In Russ.)
Views:
67
Email this article 
